Rights and permissions
About this article
Cite this article
Pharmac funds type 2 DM drug, sets 3-year funding path. Pharmacoecon. Outcomes News 461, 11 (2004). https://doi.org/10.2165/00151234-200404610-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404610-00027